Celebrating 30 years of helping you give wisely
America's most independent,
assertive charity watchdog
Top Rated

Crohn's & Colitis Foundation

CharityWatch rating issued
June 2025

Top-Rated Charity
A-
CharityWatch Rating
Our independent rating based
on a number of factors.
 
79%
Program Percentage
Amount spent on programs
relative to overhead.
 
$10
Cost to Raise $100
Amount spent to raise
$100 of contributions.

Contact Information

Crohn's & Colitis Foundation
733 Third Ave.
Suite 510
New York, NY 10017

Other Names

None

Tax Status

501(c)3

Stated Mission

To cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases.

View similar charities
Charity  
Against Malaria Foundation  
ALS Association (National Office)  
American Brain Tumor Association  
American Diabetes Association  
American Heart Association  
American Kidney Fund  
American Liver Foundation  
American Lung Association  
American Parkinson Disease Association  
American Sexual Health Association  
Arthritis Foundation  
Bone Health and Osteoporosis Foundation  
Breakthrough T1D  
BrightFocus Foundation  
CDC Foundation  
Christopher & Dana Reeve Foundation  
City of Hope & Affiliates  
Cystic Fibrosis Foundation  
Defeat Diabetes Foundation  
Diabetes Action Research and Education Foundation  
Diabetes Research & Wellness Foundation  
Diabetes Research Institute Foundation  
Easterseals (National Office)  
Elizabeth Glaser Pediatric AIDS Foundation  
Epilepsy Foundation  
Foundation for AIDS Research (amfAR)  
Hearing Health Foundation  
Heart Center of America (DISSOLVED)  
Hope Rises International  
Huntington's Disease Society of America  
Lupus Foundation of America (National Office)  
Lupus Research Alliance  
March of Dimes  
MedGlobal  
MedicAlert Foundation United States  
Mercy Ships & Affiliates  
Michael J. Fox Foundation for Parkinson's Research  
Miracle Flights  
MiracleFeet  
Multiple Sclerosis Association of America  
Multiple Sclerosis Foundation  
Muscular Dystrophy Association  
National Bleeding Disorders Foundation  
National Caregiving Foundation  
National Emergency Medicine Association (DISSOLVED)  
National Jewish Health  
National Kidney Foundation  
National Multiple Sclerosis Society  
National Psoriasis Foundation  
Operation Smile  
Parkinson Research Foundation  
Parkinson's Foundation  
Partnership for a Healthier America  
PKD Foundation  
Project Cure  
Remote Area Medical  
Salk Institute for Biological Studies  
San Francisco AIDS Foundation  
Shriners Hospitals for Children  
Smile Train  
Undue Medical Debt  
United Cerebral Palsy (National Office)  
Will Rogers Motion Picture Pioneers Foundation  
WonderWork (DISSOLVED)  
Data based on Fiscal Year Ended 12/31/2023

Program Percentage: 79%

The percentage of Crohn's & Colitis Foundation's cash budget it spends on programs relative to overhead (fundraising, management, and general expenses).

$87,000,000

Calculated Total Expenses

(rounded)

 

Cost to Raise $100: $10

How many dollars Crohn's & Colitis Foundation spends on fundraising to raise each $100 of contributions.

$68,000,000

Calculated Total Contributions

(rounded)

Government Funding

0% to 24%

Percentage of cash revenue
coming from government sources

 

Financial Documents

Entity Document Type Tax ID
Crohn's and Colitis Foundation Audited Financial Statements 13-6193105
Crohn's and Colitis Foundation IRS Form 990 13-6193105
Entity: Crohn's and Colitis Foundation
Document Type: Audited Financial Statements
Tax ID: 13-6193105
Entity: Crohn's and Colitis Foundation
Document Type: IRS Form 990
Tax ID: 13-6193105

Governance & Transparency

CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
This charity is Top-Rated
What does it mean to be Top-Rated?
 
Crohn's & Colitis Foundation
meets governance benchmarks.
 
Crohn's & Colitis Foundation
meets transparency benchmarks.
Transparency
Provides Financial Information
Audit Accessibility
Governance: Policies
Reports regularly & consistently monitoring & enforcing compliance with a written Conflict of Interest Policy
Reports required, annual disclosure by officers, directors, and key staff of interests that could give rise to conflicts
Reports having a written Whistleblower Policy
Reports having a written Document Retention and Destruction Policy
Governance: Financials
Reports providing copy of tax form to all board members prior to filing it with IRS
Reports that financial statements were audited by an independent accountant
Governance: Board of Directors
Reports at least 5 voting board members
51% or more of voting board members reported as independent
Reports documenting minutes of board and board committee meetings
Privacy Policy
Privacy Policy Opt-Out Policy  

  Name Title Compensation
1 Michael Osso President / CEO $733,035
2 Rohit Suri Chief Technology Officer $376,029
3 Michael Elkow Chief Field Officer $331,795
1
Name: Michael Osso
Title: President / CEO
Compensation: $733,035
2
Name: Rohit Suri
Title: Chief Technology Officer
Compensation: $376,029
3
Name: Michael Elkow
Title: Chief Field Officer
Compensation: $331,795

CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.

CharityWatch's rating of Crohn's & Colitis Foundation includes the financial activities of the legal entities included in its audited financial statements for the fiscal year ended 12/31/2023. According to the Crohn's & Colitis Foundation 2023 audit (Note 1 re: Organization), the audited financial statements include the financial activities of the Foundation's national office (headquartered in New York City) and its 35 chapters across the United States.

According to the Crohn's & Colitis Foundation audit of December 31, 2023 (Note 1 re: Contributed Services and Airtime), the Foundation received in-kind donated services and contributed airtime on which it placed a total value of $9,220,618. Of this amount, $1,634,669 consisted of donated services from volunteers, "comprised principally of physicians and health professionals," and $7,585,949 consisted of contributed airtime for donated public service announcements.

[Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.]

According to the Crohn's & Colitis Foundation audit of December 31, 2023 (Note 6, Loan Payable):

"On February 6, 2021, the Foundation was granted a PPP loan totaling $2,000,000. The loan was set to mature on February 6, 2026 and bore interest at a rate of one percent per annum. Under the terms of the PPP, the loan may be forgiven if the funds were used for qualifying expenses, consisting of payroll costs, rent, and utilities. On January 31, 2022, the Foundation received notice that the SBA authorized the full forgiveness of the loan. As such, the bank applied the forgiveness to the Foundation's loan account and offset all interest accrued, and PPP loan forgiveness revenue totaling $2,019,342 has been reported in the accompanying statement of activities for the year ended December 31, 2022."

According to the Crohn's & Colitis Foundation audit of December 31, 2023 (Note 1, Organization and Significant Accounting Policies, Subsequent Events):

"Management has evaluated subsequent events through October 16, 2024, which is the date the financial statements were available to be issued. The Foundation is not aware of any material subsequent events which would require recognition or disclosure in the accompanying financial statements aside from the related-party loan discussed at Note 12."

According to the Crohn's & Colitis Foundation audit of December 31, 2023 (Note 12, Related Party Transactions):

"The Foundation receives contributions from members of its Board of Trustees. For the years ended December 31, 2023 and 2022, members of the Board of Trustees contributed financial gifts of $633,071 and $1,270,439, respectively.

Included in pledges receivable are $530,632 and $100,500 due from related parties as of December 31, 2023 and 2022, respectively.

Subsequent to year-end on July 18, 2024, the Foundation signed an agreement for a $1,000.000 promissory note (the 'Note') with a Board Member. The Note's interest rate is 5.06% per annum and it matures on December 31, 2025."

According to the Crohn's & Colitis Foundation audit of December 31, 2023 (Note 13, Employee Retention Credit):

"The CARES Act provides an employee retention credit, a refundable tax credit against employment taxes of up to $5,000 per employee for eligible employers. The tax credit is equal to 50% of qualified wages paid to employees during a quarter, capped at $10,000 of qualified wages through December 31, 2020. Additional relief provisions were passed by the United States government, which extended and expanded the wage caps on these credits through December 31, 2021. Based on these additional provisions, the tax credit was increased to 70% of qualified wages paid to employees per quarter. The Foundation submitted an application for tax credits related to wages incurred during the first and second quarters of 2021. The application sufficiently met the criteria to receive the credit from the Internal Revenue Service during fiscal 2022, and therefore, the full amount of the credit totaling $3,581,000 was reported as other revenue in the accompanying statements of activities for the year ended December 31, 2022. The Foundation received payment of $3,581,084 plus related interest of $159,356 from the US Department of Treasury in August 2023."

According to the Crohn's & Colitis Foundation 2023 tax filing re: Political Campaign and Lobbying Activities (IRS Form 990, Schedule C, Part IV):

"In 2023, the Crohn's & Colitis Foundation ('the Foundation') employed the services of a professional consultant to keep the organization up-to-date on what is transpiring with federal legislation on Capitol Hill concerning health and medicine. During the year ended 2023, expenses incurred [totaled] $242,780. 

The Foundation engages in state-based advocacy campaigns ensuring that the needs of patients are addressed through legislation that targets the cost of health care and access to care. Total payments made in calendar year 2023 were $87,347.

The Foundation holds a 'Day on the Hill' event every year, in which patients suffering with IBD discuss proposed healthcare bills with legislators. The 'Day on the [Hill' event] was held virtually in calendar year 2023, for which expenses incurred were $59,712.

...Included within the $59,712 are expenses incurred for mailings made to members, legislators or the public..."

According to the Crohn's & Colitis Foundation 2023 tax filing, the Foundation reports re: Compensation, Supplemental Information (IRS Form 990, Schedule J, Part III):

Regarding participating in or receiving payments from a supplemental nonqualified retirement plan for officers, directors, trustees, key employees and highest compensated employees (Schedule J, Part I, Line 4b):

"In calendar year 2023, the President received a payout from the 457(f) plan in the amount of $125,000. This amount is reported in Schedule J, Part III and, likewise, in column (F) to reflect that it was reported as deferred compensation on prior year form 990's."

Regarding nonfixed payments to officers, directors, trustees, key employees and highest compensated employees (Schedule J, Part I, Line 7):

"The President/CEO's bonus and incentive compensation is predicated off of a set of objectives that are developed and updated each year. These objectives include raising revenues, management of expenses, development of regions and related performance, building of infrastructure and maximization of mission expenditures. Results are evaluated by the compensation and benefits committee and the incentive is ultimately determined based on ratings of performance of these objectives.

The Foundation acknowledges all of its other employees through annual lump-sum incentive awards based on meeting individual, departmental, and overall Foundation performance goals."


The Foundation reports "Bonus & incentive compensation" in the amount of $224,400 paid to Michael Osso, President/CEO; his reported total compensation in 2023 is $733,035, not including the above-mentioned $125,000 of deferred compensation. Twelve additional individuals are reported to have received "Bonus & incentive compensation" in amounts that range from $1,500 to $10,000, with total compensation ranging from $218,806 to $376,029 in 2020 (IRS Form 990, Schedule J, Part II).